Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
74.07
Nov 03 • 1:15 PM ET Dollar change-0.12 Percentage change(-0.17%)
Today, 4:01 AMAshland Inc is scheduled to announce earnings today after market close
Index
RUT
Market Cap
3.39B
Enterprise Value
4.38B
Income
52.00M
Sales
1.84B
Book/sh
40.84
Cash/sh
10.63
Employees
2900
IPO
May 08, 1950
P/E
65.52
Forward P/E
17.23
PEG
1.27
P/S
1.84
P/B
1.81
P/C
6.96
P/FCF
13.68
EV/EBITDA
11.47
EV/Sales
2.38
Quick Ratio
1.89
Current Ratio
3.05
Debt/Eq
0.79
LT Debt/Eq
0.78
Option/Short
Yes / Yes
EPS (ttm)
1.13
EPS next Y
4.30
EPS next Q
1.27
EPS this Y
3.56%
EPS next Y
22.79%
EPS next 5Y
13.53%
EPS past 3/5Y
-95.12% -15.51%
Sales past 3/5Y
-8.63% -1.98%
EPS Y/Y TTM
106.07%
Sales Y/Y TTM
-1.39%
EPS Q/Q
102.16%
Sales Q/Q
7.34%
Insider Own
1.29%
Insider Trans
0.00%
Inst Own
116.10%
Inst Trans
2.69%
ROA
1.63%
ROE
3.99%
ROIC
1.56%
Gross Margin
26.59%
Oper. Margin
8.57%
Profit Margin
2.82%
SMA20
2.44%
SMA50
3.58%
SMA200
16.01%
Trades
Shs Outstand
45.79M
Shs Float
45.20M
52W High
78.25 -5.35%
52W Low
47.12 57.18%
Volatility
2.07% 2.24%
ATR (14)
1.70
RSI (14)
61.74
Beta
0.36
Rel Volume
0.64
Avg Volume
596.51K
Volume
229,629
Perf Week
1.77%
Perf Month
7.68%
Perf Quarter
3.30%
Perf Half Y
41.72%
Perf YTD
26.24%
Perf Year
53.57%
Perf 3Y
-4.56%
Perf 5Y
-24.26%
Perf 10Y
34.90%
Prev Close
74.19
Price
74.07
Change %
-0.17%
Consensus
Buy
Avg. Price Target
$80.45
Implied Upside
+8.6%
Analysts12incl. previous ratings
Rating Distribution8 Buy · 4 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
May 06, 2026Upgrade
SSeaport Research Partners
Neutral → Buy$75+1.3%
Dec 15, 2025Upgrade
BMO logoBBMO Capital Markets
Market Perform → Outperform$71-4.1%
Sep 08, 2025Initiated
MS logoMMorgan Stanley
Equal-Weight$60-19.0%
May 01, 2025Downgrade
WFC logoWWells Fargo
Overweight → Equal Weight
Mar 26, 2025Upgrade
JPM logoJJP Morgan
Neutral → Overweight$68 → $71-4.1%
Mar 05, 2025Downgrade
SSeaport Research Partners
Buy → Neutral
Aug 08, 2024Upgrade
JPM logoJJP Morgan
Underweight → Neutral$90 → $89+20.2%
Apr 11, 2024Upgrade
WFC logoWWells Fargo
Equal Weight → Overweight$100 → $112+51.2%
Mar 14, 2024Upgrade
JEF logoJJefferies
Hold → Buy$100 → $126+70.1%
Mar 01, 2024Initiated
WWolfe Research
Outperform$108+45.8%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MUSA OSAMA MSVP and CTOSep 21 '26Option Exercise69.0610,418719,46741,224Sep 23 04:30 PM
LAMPKIN ROBIN E.SVP, GC & SecretaryAug 11 '26Option Exercise74.581,806134,6916,825Aug 12 04:30 PM
MUSA OSAMA MSVP and CTOJul 29 '26Option Exercise57.961,26773,43530,806Jul 30 04:30 PM
Assis Alessandra FaccinSVP and GM, Life SciencesJul 27 '26Option Exercise66.383,215213,4129,099Jul 29 04:30 PM
MINICUCCI JAMES P.SVP and GM, Personal CareMay 08 '26Option Exercise55.014,310237,0938,567May 11 04:30 PM
Kulkarni Ashish KDirectorJan 21 '26Option Exercise0.002,11302,113Jan 22 04:30 PM
NOVO GUILLERMOChair of the Board and CEONov 17 '25Option Exercise49.606,122303,651143,412Nov 19 04:30 PM
Drury EileenSVP and Chief HRONov 17 '25Option Exercise49.6056728,1237,881Nov 19 04:30 PM
MUSA OSAMA MSVP and CTONov 17 '25Option Exercise49.6097648,41029,875Nov 19 04:30 PM
MUSA OSAMA MSVP and CTONov 14 '25Option Exercise51.512,091107,70729,616Nov 19 04:30 PM
MUSA OSAMA MSVP and CTONov 13 '25Option Exercise53.101,39373,96828,002Nov 19 04:30 PM
RICHARDSON SAMUELVP, Controller and PAONov 17 '25Option Exercise49.601075,3071,104Nov 19 04:30 PM
WHITAKER WILLIAMSVP, CFO & PFONov 17 '25Option Exercise49.601075,3072,082Nov 19 04:30 PM
LAMPKIN ROBIN E.SVP, Gen Counsel and Secrty.Nov 17 '25Option Exercise49.6023911,8545,095Nov 19 04:30 PM
LAMPKIN ROBIN E.SVP, Gen Counsel and Secrty.Nov 14 '25Option Exercise51.511,27665,7275,237Nov 17 09:43 PM
LAMPKIN ROBIN E.SVP, Gen Counsel and Secrty.Nov 13 '25Option Exercise53.1086645,9854,220Nov 17 09:43 PM
NOVO GUILLERMOChair of the Board and CEONov 13 '25Option Exercise53.109,029479,440135,767Nov 17 09:43 PM
NOVO GUILLERMOChair of the Board and CEONov 14 '25Option Exercise51.519,119469,720141,107Nov 17 09:43 PM
Drury EileenSVP and Chief HRONov 14 '25Option Exercise51.511,29766,8087,917Nov 17 09:38 PM
Drury EileenSVP and Chief HRONov 13 '25Option Exercise53.1086345,8257,020Nov 17 09:38 PM
MINICUCCI JAMES P.SVP and GM, Personal CareNov 14 '25Option Exercise51.511,22563,1004,640Nov 17 09:38 PM
MINICUCCI JAMES P.SVP and GM, Personal CareNov 13 '25Option Exercise53.101,02054,1623,734Nov 17 09:38 PM
Assis Alessandra FaccinSVP and GM, Life SciencesNov 13 '25Option Exercise53.101,34071,1546,286Nov 17 09:37 PM
Caceres DagoSVP & GM, Specialty AdditivesNov 13 '25Option Exercise53.1074639,613746Nov 17 09:37 PM
WHITAKER WILLIAMSVP, CFO & PFONov 14 '25Option Exercise51.5135618,3382,083Nov 17 09:36 PM
WHITAKER WILLIAMSVP, CFO & PFONov 13 '25Option Exercise53.1022912,1601,797Nov 17 09:36 PM
RICHARDSON SAMUELVP, Controller and PAONov 14 '25Option Exercise51.5122811,7441,066Nov 17 09:35 PM
RICHARDSON SAMUELVP, Controller and PAONov 13 '25Option Exercise53.101467,753882Nov 17 09:35 PM
Ashland, Inc. is an additives and specialty ingredients company, which engages in the provision of architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical products. It operates through the following segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment is involved in pharmaceuticals, nutrition, nutraceuticals, agricultural chemicals, diagnostic films, and fine chemicals. The Personal Care segment consists of biofunctionals, microbial protectants, skin care, sun care, oral care, hair care, and household solutions. The Specialty Additives segment focuses on rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive, and various industrial markets. The Intermediates segment refers to production of 1,4 butanediol and related derivatives, including n-methylpyrrolidone. The company was founded in 1924 and is headquartered in Wilmington, DE.
Chairman & CEOMr. Guillermo Novo
Senior VPMr. William C. Whitaker C.F.A.
Senior VP & CTODr. Osama M. Musa Ph.D.
Senior VP & GM of Personal CareMr. James P. Minicucci
Senior VP and GM of Life Sciences & IntermediatesMs. Alessandra Faccin Assis